Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1534 of 5804
-
Migraine drug vyepti tested in kids for long-term safety
Disease control Recruiting nowThe main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
Phase: PHASE3 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New Heartburn-Free heart fix? study tests cooled catheter for racing pulse
Disease control CompletedThe WATER ATTAC study aims at multicentric, longitudinal, perspective evaluation of safety and efficacy of atrioventricular nodal reentrant tachycardia (AVNRT) performed combining irrigated ablation catheter and three-dimensional electroanatomic mapping system. Efficacy and rate …
Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New brain scan could end misdiagnosis of Parkinson's and tremor
Diagnosis CompletedClinical study to demonstrate an at least equivalent performance of a new PET molecular Imaging radiopharmaceutical named \[18F\] LBT-999 in brain imaging compared to the SPECT reference method named \[123I\]-FP-CIT to establish the differential diagnosis between Parkinson's Dise…
Phase: PHASE3 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Stem cell injection aims to heal tough fistulas in Crohn's patients
Disease control Recruiting nowThis study is a survey in Japan of Darvadstrocel injection used to treat Crohn's disease people with complicated anal fistula. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens duri…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New immunotherapy cocktail shows promise for Hard-to-Treat cancers
Disease control CompletedThe purpose of this study is to assess the safety, drug levels, immunogenicity and preliminary efficacy of BMS-986213 (nivolumab-relatlimab fixed-dose combination) in Chinese participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to find the best way to catch HPV cancers early in HIV patients
Diagnosis OngoingThis clinical trial aims to find what different tests work best to find high-grade squamous intraepithelial lesions (HSIL) in the cervix or anus in patients living with human immunodeficiency virus (HIV). Patients with HIV are at high risk of becoming infected with human papillom…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Can a simple supplement reverse muscle wasting in liver disease?
Disease control Recruiting nowLoss of skeletal muscle mass or sarcopenia is the most common and potentially reversible complication in cirrhosis that increases morbidity and mortality before, during and after liver transplantation. No proven treatments exist for the prevention or reversal of sarcopenia in cir…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Weekly shot could replace daily insulin for diabetes
Disease control CompletedThis study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine taken daily with insulin aspart in people with type 2 diabetes.The study will look at how well IcoSema controls blood sugar level in …
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control TerminatedThis is a study to understand if taking VTX002 daily as a tablet orally is safe and effective in participants diagnosed with moderate to severe ulcerative colitis (UC). Approximately 189 participants will take VTX002 Dose A, VTX002 Dose B, or matching placebo, once daily. The st…
Phase: PHASE2 • Sponsor: Oppilan Pharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for schizophrenia: valbenazine shows promise in phase 3 trial
Symptom relief CompletedThe primary objective for this study is to evaluate the effect of adjunctive valbenazine versus placebo on symptoms of schizophrenia in participants who have inadequate response to antipsychotic treatment.
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Could a diabetes drug help prevent uterine cancer?
Disease control OngoingThis phase II trial studies the effect of megestrol acetate alone or in combination with metformin in preventing the progression of uterine pre-cancer (endometrial intraepithelial neoplasia) to endometrial cancer. Megestrol acetate is a drug used to block estrogen and suppress th…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug BL-B01D1 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowIn phase Ia study, the safety and tolerability of BL-B01D1 in patients with locally advanced or metastatic solid tumor will be investigated to determine the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) of BL-B01D1. In phase Ib study, the safety and tolerability of …
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a pill shrink nerve tumors in NF1? new trial aims to find out
Disease control Recruiting nowBackground: NF1 is a genetic disease that causes tumors called atypical neurofibromas. These tumors, which arise from nerves, can cause serious medical problems. The only treatment is surgery. Researchers want to see if a drug called abemaciclib can help. Objective: To find a …
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Clip or coil? new study tests best way to stop stomach bleeding
Disease control Recruiting nowIn the management of patients with acute upper non-variceal upper gastrointestinal bleeding, further bleeding is the most important adverse factor predictive of mortality. In the United Kingdom Audit on acute upper gastrointestinal bleeding, clinical evidence of further bleeding …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New targeted drug shows promise for Hard-to-Treat cancers
Disease control CompletedA Phase I/II Study of LM-302 in Patients with CLDN18.2-Positive Advanced Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Zhejiang Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:40 UTC
-
New Four-Pronged antibody takes on advanced breast cancer
Disease control OngoingIn this study, the safety, tolerability and preliminary effectiveness of GNC-035 in participants with locally advanced or metastatic Breast Cancer will be investigated to assess the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) or maximum administered dose (MAD) for …
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
One shot, two benefits: HIV treatment and contraception combined?
Disease control Recruiting nowThe study investigators are conducting foundational pharmacokinetic (PK) and qualitative studies, among 15-24 years old (inclusive) adolescent girls and young women living with HIV (AGYWLHIV) already on oral antiretroviral therapy (ART) and virally suppressed, leading up to a hyb…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New HIV vaccine combo passes early safety check in 34 volunteers
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to evaluate the safety and immunogenicity of HIV-1 vaccines based on chimpanzee serotypes of adenovirus expressing clade C gp140 and a CH505TF gp120 protein boost in healthy, HIV- uninfected adult participants.
Phase: PHASE1 • Sponsor: HIV Vaccine Trials Network • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC
-
Could your own stem cells ease MS symptoms? new trial tests idea
Disease control CompletedRandomized Double-Blind Efficacy and safety study of Autologous HB-adMSCs versus placebo for the treatment of Multiple Sclerosis. This study will be for 24 subjects with 6 infusions over a 52 week period. Study participants will continue their established concomitant medications …
Phase: PHASE2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Drug-Free pain relief for sickle cell disease shows promise
Symptom relief CompletedThe investigators will conduct a hybrid type 1 effectiveness implementation trial to assess the effectiveness of acupuncture and guided relaxation on 360 people with Sickle Cell Disease (SCD), while observing and gathering information on implementation in three health systems: Un…
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC